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SUMMARY
In the present study, we assessed a SCN1A single nucleotide polymorphism (SNP) (rs3812718, IVS5N+5 G>A), first analyzed by Schlachter et al. We genotyped 164 patients with febrile seizures (FS) [of those 62 adults with focal epilepsy (FEFS + ) and 102 children with pure FS (Pure FS)] and 199 matched controls. Moreover, we also tested a third subgroup of 113 patients with focal epilepsy syndromes without a history of FS (FEFS ) ); they all were Caucasian. Our results, as in the initial study of Schlachter et al., showed an increase in the A-allele and AAgenotype frequencies in patients with FS compared to the controls, but these current differences did not reach statistical significance. Subsequently, we pooled our data with previously published Caucasian groups. No statistically significant difference was found for the FEFS ) , but analyses for FEFS + and Pure FS are significantly different compared to controls (p = 8.08 e )6 and p = 3.56 e )4 , respectively Febrile seizures (FS) occur in approximately 2-5% of all children younger than 6 years of age (Hauser, 1994) . Simple FS are thought to be benign, but experimental and clinical evidence indicate that the risk of developing epilepsy after FS increases if FS are prolonged and the brain is damaged. In addition, prolonged FS have many deleterious long-term effects, mainly on the hippocampus, but which may involve the whole brain.
FS are a prominent clinical feature of generalized (or genetic) epilepsy with febrile seizures plus (GEFS + ) and Dravet's syndrome, two disorders caused mainly by mutations in the voltage-gated sodium channel a1 subunit (SCN1A) gene. In light of these facts, Schlachter et al. (2009) assessed in FS patients a single nucleotide polymorphism (SNP) (rs3812718, IVS5N+5 G>A), which modifies the proportion of two SCN1A alternative transcripts.
In this earlier case-control study, the authors reported significantly higher frequencies of the A allele in patients with FS, comprising adult epilepsy patients with febrile seizures and ''pure febrile seizure'' children, compared to controls and patients without febrile seizures. The authors proposed that rs3812718 contributes to vulnerability to FS. This conclusion was not supported by a recent Australian study (Petrovski et al., 2009) , the results of which suggest that the original observation was a false positive or that the sample in this last analysis is underpowered to test for pure FS (Petrovski et al., 2009) .
In the present study, we first analyzed the same SNP in three new well-characterized samples of patients with focal epilepsy and history of FS (FEFS + ), with focal epilepsy without FS (FEFS ) ) and children with ''pure'' febrile seizure (FS) compared to matched controls. In a second step, we pooled all available data from this study and the two previous ones (Petrovski et al., 2009; Schlachter et al., 2009 ).
Patients
One hundred seventy-five adult patients (Table 1) were consecutively admitted with criteria for partial epilepsy to the Epilepsy Unit of the University Hospital of Montpellier (France). These patients have a severe form of epilepsy with poor control of their seizures, although they were treated by single drugs or a combination of drugs. Diagnosis was based on patient history, case notes, clinical examination, interictal and ictal electroencephalography (EEG) analysis carried out with monitoring video-EEG, and magnetic resonance (MR) evaluation. The study group consists of patients with a nonlesional partial epilepsy and patients with lesional partial epilepsy (vascular malformation, cortical dysplasia, nervous system tumor, and so on).
One hundred two patients with FS were admitted to the pediatric emergency rooms from the University Hospitals of Geneva, Lausanne, and Neuchâtel (Switzerland) ( Table 1) . Simple FS were diagnosed when the seizures were brief and lacked focal features, with a single seizure during a febrile illness. Complex FS were diagnosed if duration was >15 min, if focal features were present, or if multiple seizures occurred during a single febrile illness or within the first 24 h period (Consensus and statement, 1980) . A healthy Caucasian control group was recruited among blood donors from the University Hospital of Geneva (Table 1) . Only blood donors without personal and/or familial history of epilepsy and seizure were included.
All patients, controls, and parents gave informed written consent, and the study was approved by the local ethics committee. All subjects included were West European Caucasians.
Methods
All the patients and their matched controls were genotyped for rs3812718 by Simple-Probe technology. Polymerase chain reaction (PCR), performed on a final volume of 20 ll, was composed of 60 ng of genomic DNA, 0.5 lM of forward primer, 0.1 lM of reverse primer, and 0.15 lM of simple probe ''C-designed'' (Tib Mol Biol, Berlin, Germany) in solution in Light Cycler 480 Genotyping master mix (Roche, Mannheim, Germany) (primers and probe sequences available on request).
Patients with focal seizures were divided into two subgroups, FEFS + and FEFS ) , according to whether or not they had febrile seizures during childhood. Case-control genetic comparisons were performed using the chi-square test and 3 · 2 tables. The Armitage linearity tendency test was used to identify any dose effect of a susceptibility allele (Armitage & Berry, 1987) .
The statistical power to detect association was estimated using the Genetic Power Calculator (http://pngu.mgh. harvard.edu/~purcell/gpc/). Therefore, we determined that our FEFS + sample had 78% power to detect a risk genotype AA with 30% frequency, as controls, and a genotype relative risk for heterozygotes of 2, for homozygotes of 3 and using an additive genotype model at a level = 0.05. The power was 91% for FEFS ) and 90% for pure FS. Because our argument is based on previous findings and should be seen as a confirmation of previous research, we decided not to correct our results for multiple testing as we did not wish to penalize ourselves by missing potentially important findings.
Results
The rs3812718 genotypic distributions were in HardyWeinberg equilibrium among patients and at the limit in controls (p = 0.04). As reported by Schlachter et al. (2009) , we also observed an increase in the A-allele and AA-genotype frequencies in patients with FS, compared to the controls, but these differences did not reach statistical significance (Table 2) .
Because no statistical differences were observed, we successively pooled our data with those from the two previously published on Caucasian patients (Petrovski et al., 2009; Schlachter et al., 2009 ). We considered the three kinds of patients: FEFS + , FEFS ) , and FS (Table 2) . This analysis showed an increased statistical significance and a refinement of the odds ratios (ORs) 95% confidence interval (CI) compared to the initial study (Schlachter et al., 2009) . To reinforce the involvement of rs3812718, analysis between patients with FS and those without FS (Controls + FEFS ) ) showed statistical significance (p = 4.82 e )8 ) in pooled samples. Interestingly, no significant difference was found in all three studies for the FEFS ) subgroup and also for the derived pooled sample (Table 2) , suggesting that the association of FE without history of FS with rs3812718 must be firmly rejected. Conversely, it is noteworthy that both the A-allele and AA-genotype frequencies increased from controls to pure FS and FEFS + (Armitage linear tendency test: v 2 = 12.58, d.f. = 2, p = 0.01).
Discussion
In the present study we report additional patients with focal epilepsy and with febrile seizure genotyped for a putatively functional SCN1A SNP (rs3812718). We showed that this SNP is associated with FS and FEFS + when all the available Caucasian samples to date were pooled. Recall bias may have an impact on the estimated relative Schlachter et al. (2009) were used in the Petrovski study. They were thus only once considered for the ''all data combined samples.'' frequencies of FEFS + /FEFS ) and, therefore, on the association between rs3812718 and FS; however, we replicated this association in FS patients diagnosed by neuropaediatricians shortly after the seizures. We did not consider in the present study the patients from Zhang et al. (2010) , since they were from Asian origin. Difference in ethnic origin may explain the discrepancy with their results; higher frequencies of the AA genotype and the A allele in Asians would imply larger samples for demonstrating such an association (Zhang et al., 2010) . This discrepancy may also suggest that rs3812718 is not causative, but in linkage disequilibrium with the causal SNP (Zhang et al., 2010) . We concluded that the present study supports the involvement of rs3812718 in vulnerability to FS, at least in Caucasians. In addition, the increased frequencies of the A-allele and AA-genotype from controls to FS patients and then from FS patients to FEFS + ones suggest that rs3812718 is also a vulnerability factor for focal epilepsy in those patients with FS. Due to its potential clinical interest, this last hypothesis, even based on still small samples, justifies further exploration.
